-
Mashup Score: 10
Nature Cardiovascular Research – Based on the 19th Global Cardiovascular Clinical Trialists meeting, this Perspective discusses potential sources of evidence that may be used to complement…
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Kythera Labs | Kythera Labs Announces $20 Million Funding to Accelerate Growth of its Wayfinder Data Technology Platform - 5 month(s) ago
Funds will help Kythera expand its products, partnerships, and people to meet increasing demand
Source: www.kytheralabs.comCategories: General Medicine News, General HCPsTweet-
.@KytheraLabs Announces $20 Mn Funding; Wayfinder Data Tech Platform provides access to real-world healthcare data spanning over 8 yrs, including over 320 Mn lives with 29.3 Bn encounters; benefits Life Sciences' market access & commercial segments | #RWE https://t.co/zPHaoOUV98
-
-
Mashup Score: 0Atropos Health unveils AI chatbot to accelerate real-world data-based evidence generation for docs - 6 month(s) ago
Atropos Health, maker of a real-world data platform, has launched a new operating system and a chatbot interface to help generate observational studies rapidly and at scale. | Leveraging generative AI, the system helps non-technical users query real-world clinical data and get publication-grade results in minutes.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
.@AtroposHealth unveils #AI #chatbot to accelerate real-world data-based evidence generation for docs | #RWE https://t.co/kiz2qTO6tT
-
-
Mashup Score: 0
A novel study led by Friends of Cancer Research is providing evidence that tumor response rates can be assessed across real-world data sets, bringing regulators one step closer to potentially building a framework for pre-market evaluation of cancer drugs and post-market tracking of drug performance based on real-world endpoints. To access this subscriber-only content please log […]
Source: cancerletter.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The Friends of Cancer Research (@CancerResrch) pilot study measured response rates across real-world data sets in 1,400 adults diagnosed with metastatic #NSCLC who were treated with a first-line platinum doublet chemotherapy regimen. https://t.co/vLImT5E9Qe #RWE https://t.co/YIgIv3OUfq
-
-
Mashup Score: 0Supporting the Use of RWD in Oncology Drug Development - 7 month(s) ago
00:00 Stream Begins02:02 – Meeting Begins08:21 – Opening Keynote moderated by Steve Usdin featuring Amy Abernethy34:38 – Session 1: Establishing a Framework …
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed the #RWE meeting? Click to watch the full event! https://t.co/mr3ajW9ajA https://t.co/H83lj3cbvI
-
-
Mashup Score: 0Supporting the Use of RWD in Oncology Drug Development - 7 month(s) ago
00:00 Stream Begins02:02 – Meeting Begins08:21 – Opening Keynote moderated by Steve Usdin featuring Amy Abernethy34:38 – Session 1: Establishing a Framework …
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Missed the #RWE meeting? Click to watch the full event! https://t.co/6sC8nCv2aD https://t.co/oxeiGEKQSV
-
-
Mashup Score: 0Real-world data platform Atropos Health secures new funding - 7 month(s) ago
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
Source: www.mobihealthnews.comCategories: Future of Medicine, Latest HeadlinesTweet-
Real-world data platform @AtroposHealth secures new funding - The co will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets | #RWE https://t.co/5c6UIbGS2G
-
-
Mashup Score: 2Supporting the Use of RWD in Oncology Drug Department - 7 month(s) agoSource: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
This session will focus on applying learnings from Friends’ RWE pilots to support the optimal use of rw-endpoints when leveraging RWD-sources in oncology drug development and for regulatory decision-making. https://t.co/CtO3sqcwbx
-
Starting now! Session 2: Lessons Learned from Real-world Endpoint Analyses and Opportunities for Use in Drug Development. #RWE #RWEFriends https://t.co/CtO3sqcwbx https://t.co/b1JS7lChZ1
-
"We all talk about patients centeredness, but where is the information aggregated for the benefit of the patients?" @US_FDA Commissioner @DrCaliff_FDA in conversation with @PrevisionPolicy's @Kate_Rawson Join live: https://t.co/CtO3sqcwbx #RWE #RWEFriends https://t.co/shOe7kY9er
-
Lunch keynote starting now! Featuring @US_FDA Commissioner @DrCaliff_FDA in conversation with @PrevisionPolicy's @Kate_Rawson Join live: https://t.co/CtO3sqcwbx #RWE #RWEFriends https://t.co/QbxxBxuGEI
-
-
Mashup Score: 20Supporting the Use of RWD in Oncology Drug Department - 7 month(s) agoSource: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Featuring: Elizabeth Garrett-Mayer @ASCO @LGM_Biostats Amanda Bruno, @SyneosHealth Pallavi Mishra-Kalyani, @US_FDA @pmishrakalyani Yana Natanzon, @ConcertAI Nick Robert, @Ontada Lawrence Schwartz, @MSKCancerCenter https://t.co/CtO3sqcwbx
-
The presentation will describe key findings from the Friends’ rw-Response Pilot followed by a panel discussion on methodological learnings and opportunities to generate robust RWD/E. https://t.co/CtO3sqcwbx
-
Starting now! Session 1: "Establishing a Framework for Evaluating Real-world Response" In this session, discussions will focus on opportunities for using RWD to evaluate response to treatment. #RWE #RWEFriends https://t.co/CtO3sqcwbx https://t.co/t9FWb7dvbp
-
Starting now! Presentation from @BrittanyAnne340 — "Assessment of rw-Response in an Aligned #Patient Population Across #RWD Sources." Join live: https://t.co/CtO3sqcwbx #RWEFriends #RWD https://t.co/W2Inbfzros
-
"Whats different between now and 2009? Our ability to leverage technical developments." @verily's Dr. Amy Abernethy @dramyabernethy talking about #RWE with Steve Usdin @steveusdin1 @BioCentury Join live: https://t.co/CtO3sqcwbx #RWEFriends #RWD
-
"Data consent needs to match the complexity and risk of the test." @verily's Dr. Amy Abernethy @dramyabernethy talking about #RWE with Steve Usdin @steveusdin1 @BioCentury Join live: https://t.co/CtO3sqcwbx #RWEFriends #RWD https://t.co/kkuOqVHpWT
-
Starting now! Morning Keynote conversation featuring @verily's Dr. Amy Abernethy @DrAbernethyFDA moderated by Steve Usdin @steveusdin1 @BioCentury Join live: https://t.co/CtO3sqcwbx #RWEFriends #RWD https://t.co/icx1gfsZ75
-
-
Mashup Score: 0Real-world data platform Atropos Health moves into life sciences - 8 month(s) ago
Companies will have access to real-world patient data for clinical decision making and research support, including hypothesis testing, cohort analysis and more.
Source: www.mobihealthnews.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Real-world data platform @AtroposHealth moves into life sciences - Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis. | #RWE https://t.co/wx71iABd8A
-
#RWE can also be used to guide trial design & ⬇️research burden on pts/investigators ♦️define disease hotspots ♦️platforms for recruitment ♦️data re safety, effectiveness ♦️data re off-label use & outcomes -> indication extension https://t.co/Sr45DZnfBl @HeartOTXHeartMD https://t.co/nKRWPwtb2T